Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | CDC25B | P30305 | 1/20 | 0.55 |
| ▸ | TTR | P02766 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | MAPT | P10636 | 6/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 6/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.52 |
| ▸ | EGFR | P00533 | 3/20 | 0.52 |
| ▸ | RAB9A | P51151 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.52 |
| ▸ | NSD2 | O96028 | 1/20 | 0.52 |
| ▸ | MAOA | P21397 | 7/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.48 |
| ▸ | BCL2 | P10415 | 2/20 | 0.48 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10716838 | 0.93 | MAOA (0.52) | ADORA2AMEN1KMT2ACDC25BTTR | |
| SCHEMBL8669578 | 0.91 | MEN1 (0.55) | ADORA2AMEN1KMT2ACDC25BTTR | |
| SCHEMBL2072999 | 0.91 | MAPT (0.52) | ADORA2AMEN1KMT2ACDC25BTTR | |
| SCHEMBL8916299 | 0.91 | MAPT (0.54) | ADORA2AMEN1KMT2ACDC25BTTR | |
| SCHEMBL13487410 | 0.86 | PTPRC (0.57) | ADORA2AMEN1KMT2ACDC25BALDH1A1 | |
| SCHEMBL13487411 | 0.86 | PTPRC (0.59) | ADORA2AMEN1KMT2ACDC25BTTR | |
| SCHEMBL5866470 | 0.83 | CA1 (0.52) | MEN1KMT2ACDC25BTTRALDH1A1 | |
| SCHEMBL13487412 | 0.83 | CA1 (0.52) | ADORA2AMEN1KMT2ACDC25BTTR | |
| SCHEMBL3418850 | 0.83 | MEN1 (0.55) | ADORA2AMEN1KMT2ACDC25BTTR | |
| SCHEMBL8659735 | 0.82 | ADORA2A (0.41) | ADORA2AMEN1KMT2ACDC25BTTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110283064-A | A kind of 9,10- anthraquinone derivative and its preparation method and application | 武汉依麦德新材料科技有限责任公司 | 2019-09-27 | — | — | CN | claimed |
| CN-106916305-A | A kind of super cladodification polyimides containing anthraquinone ring and preparation method thereof | 宁波祢若电子科技有限公司 | 2017-07-04 | — | — | CN | claimed |
| US-5385842-A | Anthraquinones as inhibitors of sulfide production from sulfate-reducing bacteria | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-01-31 | — | — | US | claimed |
| EP-0525073-B1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | DU PONT (US) | 1994-05-25 | — | — | EP | claimed |
| EP-0525073-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA. | DU PONT (US) | 1993-02-03 | — | — | EP | claimed |
| WO-1991015954-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-31 | — | — | WO | claimed |
| CN-117597327-A | Pharmaceutical preparation | 第一波动生物制药股份有限公司 | 2024-02-23 | — | — | CN | disclosed |
| US-20200270200-A1 | DEUTERATED COMPOUNDS AND USES THEREOF | OncoTherics Ventures Limited (GB) | 2020-08-27 | — | — | US | disclosed |
| CN-110283064-A | A kind of 9,10- anthraquinone derivative and its preparation method and application | 武汉依麦德新材料科技有限责任公司 | 2019-09-27 | — | — | CN | disclosed |
| US-10385009-B2 | Deuterated compounds and uses thereof | BIOSTATUS LIMITED (GB) | 2019-08-20 | — | — | US | disclosed |
| EP-2882708-B1 | NEW COMPOUNDS AND USES THEREOF | BIOSTATUS LTD (GB) | 2018-10-03 | — | — | EP | disclosed |
| EP-1948738-B1 | COLOURED PARTICLES FOR ELECTROPHORETIC DISPLAYS | BASF SE (DE) | 2018-02-28 | — | — | EP | disclosed |
| CN-106458821-A | BH4 antagonists and methods related thereto | 爱默蕾大学 | 2017-02-22 | — | — | CN | disclosed |
| WO-2007048722-A2 | PROCESS FOR HAIR DYEING COMPRISING APPLICATION OF COMPOSITE PIGMENT | CIBA HOLDING INC. (CH) | 2007-05-03 | — | — | WO | disclosed |
| WO-2007048721-A1 | COLOURED PARTICLES FOR ELECTROPHORETIC DISPLAYS | CIBA HOLDING INC. (CH) | 2007-05-03 | — | — | WO | disclosed |
| US-6919453-B1 | Colorant compositions | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2005-07-19 | — | — | US | disclosed |
| US-5385842-A | Anthraquinones as inhibitors of sulfide production from sulfate-reducing bacteria | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-01-31 | — | — | US | disclosed |
| EP-0525073-B1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | DU PONT (US) | 1994-05-25 | — | — | EP | disclosed |
| EP-0525073-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA. | DU PONT (US) | 1993-02-03 | — | — | EP | disclosed |
| WO-1991015954-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10385009-B2 | Deuterated compounds and uses thereof | HIF1AN, HIF1A, EGLN2 | ADORA2A 1782/4885MEN1 2943/4885KMT2A 2099/4885 |
| US-20200270200-A1 | DEUTERATED COMPOUNDS AND USES THEREOF | HIF1AN, HIF1A, EGLN2 | ADORA2A 1800/4885MEN1 2862/4885KMT2A 2124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.